Introduction
The "professional" phagocytic cells, neutrophils, monocytes, macrophages, and eosinophils, demonstrate markedly enhanced oxygen consumption when engulfing their prey. This "extra respiration of phagocytosis" was first observed in 1933 (1) but the unusual nature of the process was only revealed in 1959 when it was discovered that it was not inhibited by classical mitochondrial poisons such as cyanide and azide (2), indicating that it was not simply a reflection of the enhanced energy requirements of phagocytosis. This "respiratory burst" was soon discovered to be a requirement for the efficient killing of bacteria by neutrophils (3), the veracity of this observation being rapidly reinforced by the identification of a new syndrome, "fatal granulomatosis of childhood" (now referred to as chronic granulomatous disease [CGD] ),' in which a severe predisposition to pyogenic infection was associated with complete absence of this oxidase activity from the patients phagocytes (4) .
An extensive series of investigations have been undertaken in an attempt to define the nature of this oxidase and the molecular basis of CGD. These studies have taken three main directions: the isolation of the intact functional oxidase, the identification and purification of its components, and the reassembly of these components to reconstitute a functional system. In each case, cells from patients with CGD have played an important role in the experimental approach. This perspective article will outline the current state of knowledge that has resulted from these studies and derive a model to account for their findings and to explain the molecular pathology ofCGD.
Early attempts to identify the oxidase system in cells, organelles, and extracts
The earliest experiments attempted to purify the oxidase from whole-cell homogenates and crude subcellular fractions. These were incubated with a variety of potential substrates in an attempt to demonstrate oxidase or diaphorase activity (5) . The dramatic increase in the activity ofthe hexose monophosphate shunt in association with the respiratory burst (6) indicated one of its products, NADPH (7) , as the most physiological of these substrates. A variety of activities were detected, but the interpretation of these experiments was complicated by the lack of specificity of the oxidation of many of these substrates and the autocatalytic nature ofmany ofthe resulting reactions. A number of "enzymes" were discovered and described as defective in CGD (5) .
The next advance in this approach came with the solubilization ofan active oxidase from activated cells (8) . Despite this achievement, complete purification of the source ofthe detectible activity was prevented by the instability of the system, particularly its exquisite sensitivity to salts, which prevented separations on most chromatographic media (9) . Purifications of the "oxidase" by these methods were probably separating a proximal component ofthe system, as will be elaborated upon below.
Identification ofcytochrome b-245 and recognition ofthe oxidase as an electron transport chain
In 1978 a b-type cytochrome was identified in human neutrophils (10) , having been previously seen in animal cells (1 1) . This discovery seemed significant inasmuch as this was the sort of molecule that might be expected to accomplish the one electron reduction of oxygen to form superoxide, and pointed the way to the identification of the "NADPH oxidase" as an electron transport chain rather than a single enzyme.
In humans this cytochrome was found in the professional phagocytic cells, neutrophils, monocytes, macrophages, and eosinophils, but not in a variety of other cell types (12) . Its identity in these different cells was established by the determination ofits midpoint potential (Em7.0, see below). It is present in myeloid HL-60 (13) and U937 (14) cell lines. In the former the induction of differentiation with dimethyl sulphoxide was associated with the development of oxidase activity and a parallel increase in the concentration ofthis cytochrome (13) .
In these cells it is found in the plasma membrane and becomes incorporated into the wall of the phagocytic vacuole as this is formed by an invagination ofthis membrane (15) . In neutrophils an additional pool ofthe cytochrome is detected in the membrane of the specific granules which also transfers to the membrane of the phagocytic vacuole (16) . BIOCHEMICAL 
PROPERTIES
Spectroscopy in alkaline pyridine reveals the spectrum of a protoheme pyridine hemochrome characteristic of a b-type cytochrome (17) , which is present in neutrophils and monocytes at a concentration of 100 pmol/mg protein (18) . The function of a redox molecule is largely dependent upon its midpoint potential (19) , at which it is balanced between oxidation and reduction, which governs its bioenergetic stature in the heirarchy of components ofan electron transport chain. At 245 mV (20) this cytochrome has the lowest midpoint potential of any mammalian cytochrome b, which provides it with the capability of directly reducing oxygen to superoxide (21). This measurement gives a considerable degree of discrimina-tion between otherwise apparently similar molecules and it is for this reason that we refer to it as cytochrome b-245. It is also called "cytochrome b558," the 558 referring to the wavelength of its a band of light absorption.
Another unusual property of this cytochrome, not seen in other mammalian cytochromes b but shared with bacterial cytochromes o (22) , is that it binds CO (20, 23) (recombination time after flash dissociation of the complex of -6 mis). This property indicates that it probably binds oxygen (the oxidation ofthe reduced cytochrome is very rapid with a half-time of4.7 ms [23] ) and represents the terminal component of the electron transport chain.
NADPH reduces the cytochrome in preparations of the solubilized oxidase, but only at a very slow rate. This slow rate of reduction had been thought by some (24) to preclude its participation as a component of the oxidase. The kinetics of reduction of a molecule in an electron transport chain under anaerobic conditions might bear no relationship to its normal physiological function in the presence of an electron acceptor which can help to pull electrons through the system. When the steady-state kinetics of reduction of the cytochrome were determined in the presence of oxygen, they correlated almost exactly with the observed rate of O2 generation (25).
PURIFICATION AND IDENTIFICATION OF CYTOCHROME b-245
The purification of this molecule and identification of its apoprotein polypeptide proved difficult. The four initial purification schemes described isolated polypeptides of different molecular weights, varying between 11,000 and 127,000 (26) (27) (28) (29) . The main causes ofthese difficulties in the identification ofthe molecule were proteolysis, the neutrophil being richly endowed with a wide range of potent proteolytic enzymes, and anomalous behavior of the apoprotein(s) on sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (30) .
Two reliable methods now exist for the purification of this cytochrome, both of which resulted in the purification of not one but two proteins, with molecular weights of 76,000-92,000 and 23,000 as determined by mobility on SDS-PAGE. SUBUNIT 
STRUCTURE
The association of the 23,000-mol wt a and 76,000-92,000-mol wt , subunits has been established by their copurification with the heme of the cytochrome; their association on gel filtration chromatography, sucrose density, and pH gradients; cross-linking studies; and the absence of both proteins from cells of patients with X-linked CGD (31) (32) (33) . A number of these heterodimers might be associated to form a macromolecular complex. (37) (38) (39) . After having discovered this cytochrome b, it was of considerable interest to determine whether its absence was responsible for the defective function ofthe electron transport chain in cells from these patients.
With few exceptions the cytochrome has been found by spectral analysis to be missing from cells of subjects with the more common inheritance through a lesion on the X chromosome and normal in those with an autosomal recessive pattern (18, 37, 38) . In addition, both subunits ofthe cytochrome were shown to be absent from the patients' cells in X-linked CGD (31) , confirming the association ofthese proteins as subunits of the cytochrome, but providing no indication as to the nature of the genetic lesion.
Cloning ofthe genefor the (3-subunit ofcytochrome b-245
The genetic lesion in most patients with X-linked CGD was identified through the elegant application of "reverse genetics" (34) . DNA from a very unusual patient with a deletion of a small segment ofthe short arm ofthe X chromosome was used in a subtractive hybridization to enrich in normal DNA from the region of the deletion. This DNA was cloned (40) and the library probed with cDNA prepared from (34) an induced HL-60 cell line subtractively hybridized with RNA from another CGD patient with a small deletion on the short arm of the X chromosome. Clones were identified that hybridized with RNA with a 5-kb message, showed the appropriate tissue specificity and were induced in HL-60 cells in association with induction of the oxidase. Confirmation of the connection between this gene (labeled the "X-CGD gene") and the oxidase was supplied by the demonstration that monocytes from three of four X-linked CGD patients failed to transcribe complementary RNA. Although cells from a fourth such patient did transcribe the gene, it showed an abnormal pattern of cleavage by restriction enzymes, the patient's mother being heterozygous for this abnormality.
In having identified the abnormal gene by these methods, the protein for which it coded was predicted but not identified. In particular, it did not show sequence homology with cytochromes b.
Starting with the pure cytochrome, we were able to dissociate the two subunits by denaturation and then separate them by gel filtration. The sequence of 42 (45), and there is a lot of evidence to suggest that this is correct and that the cofactor is flavin adenine dinucleotide (FAD) (5, 7, 8) . The activity of a solubilized preparation of the oxidase is inhibited by flavin analogues like 5-carba-deaza-FAD (46) and the possible flavoprotein inhibitor diphenylene iodonium (47) . A fluorescent flavoprotein has been described in neutrophil membranes (48) . FAD in membranes and membrane extracts is reduced by NADPH under anaerobic conditions (49, 50), and a flavin semiquinone electron spin resonance spectrum has been observed in membranes from activated neutrophils in the presence of NADPH (51) . A number of groups have approached the identification of the oxidase by solubilizing and purifying oxidase activity, and have isolated a protein with a molecular weight of -65,000-67,000, which in most cases appears to be a flavoprotein (9, 52, 53). Unfortunately, the oxidase activity is very unstable so that the recovered activity of -5% (9, 52) 
Flavoproteins in CGD
The 66,000-mol wt, membrane-related NADPH-binding protein has been shown to be present in cells of patients with X-linked and with autosomal recessive CGD (56) . This was an interesting finding because flavoprotein concentrations of about half-normal have been detected in membranes from neutrophils in a large proportion ofthe cases of X-linked CGD (37, 38, 48, 57) , suggesting the participation of a flavoprotein other than the 66K in this system. The absence of this protein in association with that of the cytochrome b might suggest the same sort of structural relationship between these molecules as appears to exist between the 47,000-mol wt phosphoprotein (described below) and the cytochrome b (58).
47,000-mol wt phosphoprotein and its abnormality in CGD Although cells from these patients contain normal amounts of an apparently normal cytochrome b (18), they are unable to pass electrons along the chain onto this cytochrome (59) . This indicates an abnormality of the activation process or the ab-sence or malfunction ofa proximal electron transferring molecule, or molecules.
Activation mechanisms in neutrophils (7) are currently the focus of considerable interest. One of the major common pathways appearing to be through the phosphorylation of the target protein by protein kinase C, which is directly activated by phorbol myristate acetate (PMA), a potent stimulus of the oxidase system (60).
It thus seemed pertinent to determine the pattern of protein phosphorylation in cells from these patients after activation with PMA, the hypothesis being that a general abnormality of activation would be identifiable by the failure to phosphorylate a number of bands and a defect of a specific target would be revealed by a single missing or aberrant band. In fact, the second possibility proved correct with the consistent absence of a 47,000-mol wt phosphoprotein from the cells of these patients (61-63) .
The normal protein, but not that from the cells of these patients, could be phosphorylated by protein kinase C in vitro after extraction from SDS-PAGE gels (64) . This could indicate that the amino acid target ofphosphorylation, usually serine or threonine, has been replaced as a result of a base substitution in the gene, but the evidence suggests the protein itself to be missing (65 (70) . Curiously, the same purification was initially described as yielding only one major band with a molecular mass of 65 kD (9) . Reconstitution ofafunctional oxidase by the recombination ofneutrophil subcellular compartments An advance in our understanding of the oxidase was achieved by the discovery that the system could be induced to function in a "cell-free" system ofdisrupted constituents ofunactivated cells by the addition of a detergent, SDS (71) and. later by arachidonic acid (72, 73) . Subsequently, separated membranes and membrane extracts, and cytosol could be recombined to restore function, identifying functional components of this system in both these cellular compartments (35, [73] [74] [75] [76] [77] .
A functional system could not be reassembled when CGD cells were used. By mixing of normal membranes and cytosol with those from patients, it was possible to localize the site of their lesions. Predictably, in X-linked CGD the absence of the b-type cytochrome was associated with a defect in the membrane fraction, whereas, patients with autosomal recessive CGD in whom the 47-kD band of protein did not become phosphorylated, had abnormal cytosol (63, 78, 79) .
Kinetic data suggested the requirement for more than one cytosolic factor (76) , and this was confirmed when the cytosolic requirements of this reconstituted system were further defined after separation of the proteins on an anion exchange column (63). It was shown that three components could be defined, called neutrophil cytosol factor [1] [2] [3] (NCF), in their order of elution from the column, which together could replace the cytosol in the reconstituted system. NCF-1 could correct the defect in the cytosol of all but one ofthe autosomal recessive patients. NCF-2 corrected the cytosolic deficiency in the single patient whose cell extracts did not respond to NCF-I and who was shown to have a different anomaly on the basis of complementation studies. Unlike all the others, the 47,000-mol wt phosphoprotein in his cells was normally phosphorylated upon activation. Independently, another group of investigators had raised an antiserum to cytosolic proteins eluted from a GTP affinity column which reconstituted activity, which resulted in antibodies predominantly to proteins with molecular weights of 47,000 and 65,000 (80). Rather fortuitously, these 47,000-and 65,000-mol wt proteins were located in the NCF-l and NCF-2 fractions, respectively, and Western blotting studies indicated that the autosomal recessive patients lacking NCF-I and NCF-2 activity were also missing the corresponding protein from their cytosol (63, 80).
These studies indicate that most autosomal recessive patients are lacking a cytosolic factor, NCF-1, almost certainly the 47,000 phosphoprotein. NCF-2 appears to be a protein with a molecular weight of 65,000, very close to that of the putative NADPH-binding flavoprotein. This might suggest that NCF-2 and the 66,000-mol wt flavoprotein are one and the same. However, this seems unlikely in that the former is cytosolic, moving into the membranes upon activation, whereas the latter has been clearly identified within the membrane fraction of unstimulated neutrophils (53, 56) (79) observed the effect of IFN-,y on oxidase activity of cultured monocytes. All but 1 of the 13 autosomal recessive subjects whose cells contained cytochrome b showed increased activity, from undetectable levels to -14% of normal. The autosomal recessive patient without the cytochrome did not demonstrate activity before or after treatment. X-linked cytochrome b-deficient subjects clearly fell into two groups: 9 of the 13 showed no response; restitution of activity was partial in three and complete in the remaining one. An incomplete response was also seen in the unusual X-linked patient whose cells contained the cytochrome. "Variant" patients with an incomplete defect also demonstrated improved activity. The response was maximal at a concentration ofIFN-y ofabout 1,000 U/ml and evolved over -48 h. In vivo responses in neutrophils and monocytes were of the same order of magnitude as seen in vitro and also took -3 d to reach maximum.
These changes in oxidase activity were reflected by changes in the expression of the genes for, and the tissue levels of, cytochrome b-245 (36). Incubation with IFN-'y markedly increased the mRNA transcript for the large / subunit of the cytochrome in neutrophils, monocytes, and cell lines of the myeloid lineage to about three to five times the levels in untreated cells. These changes were maximal after -24-48 h. Transcript levels for the light a subunit were unchanged. Nuclear runoff studies demonstrated accelerated transcription rather than delayed removal as the basis of the accumulated message for the /3 subunit.
Tumor necrosis factor has been shown to have similar effects to IFN-'y, and to act synergistically with it, on the gene for the /3 subunit and on the expression of oxidase activity (84). The effects of these mediators on oxidase activity and mRNA levels for the /3 subunit of the cytochrome are mirrored by cellular levels of cytochrome b, as measured spectrophotometrically or immunologically.
The changes in oxidase activity in neutrophils and monocytes that resulted from the administration of IFN-'y to patients with CGD were associated with marked improvements in bacterial killing, which virtually returned to normal at levels of oxidase activity at 10% of normal (79) . Interestingly, killing by neutrophils of some patients was enhanced in the absence of detectable induction of superoxide generation, suggesting some other influence on the biology of these cells, whose microbicidal capability is not solely related to the oxidase system, as will be discussed below. Given the dramatic response in a number of these patients to exogenous IFN-'y, it is interesting to consider why the same changes are not seen as a result of the endogenous secretion of this compound in the setting of chronic inflammation that most of them sustain. Other cytokines are also secreted under these conditions and might compete with IFN-,y and downregulate this system. In this context IFN-a, which suppresses the respiratory burst, has been shown to reduce transcription of the gene for the /3 subunit of the cytochrome (36).
A unifying model ofthe oxidase electron transport chain and its relationship with the different subtypes ofCGD
On the basis of the information outlined above it is possible to construct a model of the oxidase system and to postulate the molecular basis for the different subgroups of CGD (Fig. 1) . Cytochrome b-245 is almost certain to represent the terminal component of the chain. It appears to bind oxygen, the final electron acceptor, and has a rapid oxidation rate in keeping with a terminal oxidase and a sufficiently low midpoint potential to permit the direct reduction of oxygen to superoxide. Glycosylation of the /3 subunit suggests a location on the external surface of the plasma membrane for this molecule, the surface from which the superoxide is released. The location of the smaller a subunit is unknown. Both subunits are phosphorylated upon stimulation of the oxidase, suggesting a requirement for changes in conformation to achieve the active state.
The 47,000-mol wt phosphoprotein is cytosolic and is phosphorylated upon activation of the cell. It then moves into the membranes where it attaches to a binding site on the cytochrome b. It might itself be an electron-transporting mole- The oxidase consists of an electron transport chain that is interposed between the substrate, NADPH, in the cytosol, and the lumen of the phagocytic vacuole. Electrons are pumped across this membrane to reduce oxygen to superoxide, thereby elevating the pH within the vacuole. The clearly defined components of this chain include cytochrome b-245, with a large ,B and a 28,000-mol wt a subunit, and a 47,000-mol wt cytosolic protein that, upon activation of the system, becomes phosphorylated by a kinase using ATP as substrate, and moves into close association with the cytochrome in the membrane. The proximal molecule could be a flavoprotein with a molecular weight of 65,000-67,000 located in the membrane, representing a 66,000-mol wt NADPH-binding protein located in the membrane from the outset, or a 65,000-mol wt cytosolic factor that moves into the membrane upon activation, or possibly both. In most cases, X-linked CGD results from a defect in the gene coding for the /3 subunit of the cytochrome, whereas in the majority of those with the autosomal recessive inheritance the lesion affects the 47,000-mol wt phosphoprotein. K, molecular weight in thousands.
cule or could play a structural or regulatory role in the integration or activation ofthe chain. Stimulation ofneutrophils is followed by variable delay before triggering of the NADPH oxidase. This takes -20-30 s after the addition of the C-kinase activator PMA, but is much more rapid after exposure to the chemotactic peptide FMLP (85). The latter may trigger the burst without obvious phosphorylation of the 47,000-mol wt phosphoprotein (86) . It is possible that the lag phase reflects the time taken for phosphorylation of this protein, its translocation into the membrane, and its association with the cytochrome b. The interaction of FMLP with its receptor might induce the integration ofthe components ofthe chain without the requirement for phosphorylation. The failure of FMLP to activate the oxidase in autosomal recessive CGD in which the 47,000-mol wt phosphoprotein is defective indicates the requirement for this component whether or not phosphorylation is observed.
There is clearly a requirement for a 65,000-mol wt cytosolic factor that must move into the membranes upon activation of the system. Whether this is the proximal NADPHbinding flavoprotein or it intercalates into the chain distal to a 66,000-mol wt membrane protein with these characteristics remains to be resolved.
It has been found that this system can be "primed" by the exposure of cells to concentrations of stimuli below those required for activation of the oxidase. This priming, which results in a decrease in the lag before activation, and amplifies the response, could involve phosphorylation and partial assembly ofthe components of the chain.
Modelsfor the different types ofCGD
The defective gene in X-linked CGD is that coding for the large , subunit ofthe cytochrome b. The most common result of an abnormality of this gene is the failure of transcription of its message, as well as that of the smaller a subunit, and the complete absence of both proteins from the patients' phagocytes. The genetic lesion is likely to preclude any expression of the cytochrome in the majority of these patients in whom the oxidase system shows no response to (95) . The anomaly is that the same proteins are much less effective when released onto the same organism within the phagocytic vacuole ofa neutrophil in the absence of oxidase activity under anaerobic conditions or in CGD. This must indicate an impairment of the action of these proteins within this environment. One way in which this might occur could be through variations in vacuolar pH.
In CGD, and in normal cells in the absence of oxygen, the early elevation of pH is not observed and the pH falls precipitously below neutral to -1.5 pH units lower than normal (89) . This is important because it has been demonstrated that bacterial killing by the granule cationic proteins is only observed at pHs above 7.0 (95). This would explain the reason that CGD cells kill most, but not all ingested organisms (89) .
Microbes entering the vacuole early after phagocytosis will be exposed to granule contents while the pH is still neutral and will be killed, whereas those that are slightly more resistant or are sequestered within a clump of organisms, might survive until the pH has fallen to safer levels.
Not all the features of CGD can be explained in terms of their predisposition to infection. Granulomata develop in the absence of active infection and the macrophages are engorged with lipid rather than invading microbes. The phagocytic vacuoles of CGD neutrophils remain much smaller than normal (89, 96) , and some patients develop massive unexplained hepatosplenomegaly. In fact, the original description of the histology in CGD concluded that the appearances more closely resembled a storage disease like Niemann-Pick disease than infection, but were unable to explain the mechanism by which this might occur (97). Neutrophil, monocyte, and macrophage granules contain a potent array of digestive enzymes that are largely active at neutral pH. It was therefore predictable that the abnormal acidity of the phagocytic vacuoles in CGD would impair this function (89) and result in the accumulation of indigestable debris. In fact, CGD mirrors Niemann-Pick in being a storage disease as a result of the failure of degradation. However, in CGD this occurs not because of an absence of the hydrolytic enzyme, but rather as a consequence of the impairment of the activity of normal enzymes by an inclement milieu. This realization permits the use of maneuvers to neutralize the pH within the vacuoles of these patients as an additional approach to the alleviation of the manifestations of CGD. It will be of interest to see the effects of IFN-'y and other cytokines on the indigestion normally suffered by phagocytes in these patients.
